Ragwitek FDA Approval History
FDA Approved: Yes (First approved April 17, 2014)
Brand name: Ragwitek
Generic name: ragweed pollen allergen extract
Company: Merck
Treatment for: Allergic Rhinitis
Ragwitek (short ragweed pollen allergen extract) is a sublingual immunotherapy for the treatment of ragweed allergies.
Development timeline for Ragwitek
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.